Tracking Medicare news, policy, and coverage changes.
Four years after the Volunteer State enacted the nation’s first law allowing drugstores to sell ivermectin without patient-specific prescriptions, dozens of pharmacies dispense the drug in highly concentrated pills — many with the help of one anti-vaccine physician.
Read full article →Amid advancements in treatment and screening, more Americans are surviving the disease. But many are left with psychological scars, such as lingering anxiety and depression.
Read full article →Congressional Democrats are seeking to overturn a Trump administration rule they say will hamper Obamacare coverage. Whether they win or lose any floor vote, they’ll likely use it in campaign messaging ahead of the midterms.
Read full article →Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
Read full article →“‘Health care’ is such a big word for STAT. It’s a cornerstone of our coverage,” says STAT director of editorial operations Sarah Mupo.
Read full article →“The privilege of oncology is not only that you get to cure people,” writes oncologist Khushali Jhaveri. “It is also that you are invited into the most honest rooms in…
Read full article →“As a physician and former public health official, I have never been more concerned about those rates of congenital syphilis,” writes Jeffrey D. Klausner.
Read full article →InStride’s Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures. The post InStride Raises $30M to Scale Pediatric Mental Health Support appeared first on MedCity News .
Read full article →MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. The post New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug appeared first on MedCity News .
Read full article →(MedPage Today) -- Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna's mRNA flu vaccine candidate for adults 50 and older, which has the potential to become the first such...
Read full article →(MedPage Today) -- Health Secretary Robert F. Kennedy Jr. this week refused to release a cruise ship passenger exposed to hantavirus in early May from a quarantine facility in Nebraska -- despite a federal medical review that said there's no...
Read full article →(MedPage Today) -- Legal and public health experts expressed concern about HHS Secretary Robert F. Kennedy Jr.'s scrutiny of a medical journal's decision to remove a study that purportedly suggested an increased incidence of sudden infant death...
Read full article →